keyword
https://read.qxmd.com/read/38619581/a-case-of-rapid-avacopan-induced-liver-injury-in-pediatric-granulomatosis-with-polyangiitis
#1
JOURNAL ARTICLE
Tomohiko Nishino, Shinya Tomori, Mei Haruyama, Kazuhiro Takahashi, Masakazu Mimaki
Children with anti-neutrophil cytoplasmic antibody-associated vasculitis benefit immensely from avacopan as it reduces the requirement for steroids. However, descriptions of adverse drug reactions in children are lacking, and the dosage and follow-up intervals are unclear. A 10-year-old boy with initial granulomatosis and polyangiitis presented with diffuse pulmonary hemorrhage. Rituximab and 30 mg avacopan were administered twice daily as induction therapy following methylprednisolone pulse therapy. However, sudden liver function test abnormalities were observed on day 31 of avacopan treatment, despite liver enzyme levels being within the normal range 5 days earlier...
April 15, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38619380/safety-and-effectiveness-of-certolizumab-pegol-in-japanese-patients-with-rheumatoid-arthritis-up-to-3-year-results-from-a-postmarketing-surveillance-study
#2
JOURNAL ARTICLE
Hideto Kameda, Keiichiro Nishida, Toshihiro Nanki, Akira Watanabe, Yukiya Oshima, Shigeki Momohara
OBJECTIVES: To report up to 3-year safety and effectiveness of certolizumab pegol (CZP) in Japanese patients with rheumatoid arthritis from a postmarketing surveillance study. METHODS: Patients enrolled previously completed 24 weeks of CZP in the 24-week postmarketing surveillance study. Adverse drug reactions (ADRs) were recorded for patients who received ≥1 CZP dose. Effectiveness outcomes were 28-joint Disease Activity Score with erythrocyte sedimentation rate and European Alliance of Associations for Rheumatology response...
March 29, 2024: Modern Rheumatology
https://read.qxmd.com/read/38619027/exploring-the-impact-of-co-exposure-timing-on-drug-drug-interactions-in-signal-detection-through-spontaneous-reporting-system-databases-a-scoping-review
#3
REVIEW
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
INTRODUCTION: Drug-drug interactions (DDIs) are defined as the pharmacological effects produced by the concomitant administration of two or more drugs. To minimize false positive signals and ensure their validity when analyzing Spontaneous Reporting System (SRS) databases, it has been suggested to incorporate key pharmacological principles, such as temporal plausibility. AREAS COVERED: the scoping review of the literature was completed using MEDLINE from inception to March 2023...
April 15, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38618912/doxycycline-induced-gastric-injury
#4
JOURNAL ARTICLE
H H W Liu, T W Ho, N S K Tsang, J T W Lam, Y T Hui
No abstract text is available yet for this article.
April 15, 2024: Hong Kong Medical Journal
https://read.qxmd.com/read/38618373/metronidazole-induced-acute-cerebellitis-in-a-young-patient-unusual-onset-delayed-remission-and-characteristic-imaging-features
#5
Venkat Reddy, Sunil Kumar, Sourya Acharya, Jasleen Kakkad, Mamtha Jadhav
Metronidazole-induced acute cerebellitis is an exceptionally rare condition resulting from severe adverse reactions to metronidazole, a medication generally employed in the management of infections caused by anaerobic microbes. Although neuropathy has been linked to metronidazole use, reports of acute cerebellitis are infrequent. The neurological effects associated with metronidazole can include weakness, dysarthria, postural instability, seizures, giddiness, vertigo, ataxia, confusion, encephalopathy, headaches, and tremors...
March 2024: Curēus
https://read.qxmd.com/read/38618137/maximum-tolerated-dose-and-toxicity-evaluation-of-orally-administered-docetaxel-granule-in-mice
#6
JOURNAL ARTICLE
Xiaowei Dong, Jinmin Zhang
Oral delivery of chemotherapy drugs is the most favorable and preferred route of drug administration. However, because of poor solubility and/or permeability, most chemotherapy drugs are given by intravenous administration. Docetaxel (DTX) is a potent chemotherapy drug that inhibits microtubular depolymerization and is widely used to treat numerous cancers. DTX is highly lipophilic and insoluble in water; thus, 50% polysorbate 80, which may cause hypersensitivity reactions and reduce drug uptake by tumor tissue, is used in the commercial DTX injection to dissolve DTX...
June 2024: Toxicology Reports
https://read.qxmd.com/read/38618136/the-addition-of-mammalian-cell-culture-medium-impacts-nanoparticle-toxicity-in-zebrafish
#7
JOURNAL ARTICLE
John V Lam, Ryan L Lopez, Lisa Truong, Robyn L Tanguay
Engineered nanomaterials (ENMs) are ubiquitous in contemporary applications, yet their environmental and human health impacts remain inadequately understood. This study addresses the challenge of identifying potential risks associated with ENM exposure by highlighting the significant variability in existing research methodologies. Without a systematic collection of toxicological data that encompasses standardized materials, relevant platforms, and assays, the task of identifying potential risks linked to ENM exposure becomes an intricate challenge...
June 2024: Toxicology Reports
https://read.qxmd.com/read/38617895/analysis-of-a-serious-adverse-reaction-of-pulmonary-fibrosis-caused-by-dronedarone
#8
Yuyan Chen, Zhendong Fu, Xue Wen, Mingxia Zhang, Qiong Min, Peng Wang, Jin Zhang, Jun Ren, Wenbin Li, Rong Wang
OBJECTIVE: This study aims to analyze a severe adverse reaction of pulmonary fibrosis induced by dronedarone hydrochloride tablets, and to provide a reference for clinical rational medication through drug precautions. METHODS: A case of pulmonary fibrosis induced by dronedarone hydrochloride tablets, along with related literature was retrospectively analyzed. RESULTS: Patients over 65 years old with a history of exposure to amiodarone may increase the incidence of pulmonary toxicity induced by dronedarone, and dronedarone should not be selected as a substitute treatment drug for patients with amiodarone-induced pulmonary toxicity...
2024: Current Therapeutic Research, Clinical and Experimental
https://read.qxmd.com/read/38617769/clinical-use-of-macitentan-in-the-treatment-of-connective-tissue-disease-associated-pulmonary-arterial-hypertension
#9
JOURNAL ARTICLE
Xiaohui Song, Xiangrui Sheng, Lei Ding, Jian Wu, Xin Chang, Erye Zhou, Jing Cao, Tao Cheng, Mingjun Wang
BACKGROUND: Connective tissue disease (CTD) is the second most common cause of the pulmonary arterial hypertension (PAH). Currently, clinical data concerning CTD-PAH is scarce. Our study aimed to assess the efficacy and safety of macitentan in the treatment of CTD-PAH. METHODS: In this retrospective study, patients diagnosed with CTD-PAH at The First Affiliated Hospital of Soochow University from April 2020 to November 2021 were included. Of the patients, 9 were switched to macitentan monotherapy whereas 23 received initial combination therapy...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38617722/topiramate-induced-ocular-complications-case-series
#10
Sarita Lobo, Geover Joslen Lobo
UNLABELLED: Several ocular adverse effects have been attributed to Topiramate, a sulfonamide derivative. It can cause problems in the eye such as choroidal effusion syndrome, acute angle closure glaucoma, myopic shift, visual field defects, and Myokymia. If not identified early, it can be vision-threatening. It is commonly used for migraine prophylaxis, partial onset, and generalized tonic-clonic seizures. It has also been prescribed for bipolar disorder and alcoholism. The risk of adverse reactions with this drug is 3%...
2024: Romanian Journal of Ophthalmology
https://read.qxmd.com/read/38616741/sirna-mediated-knockdown-of-abcb1-enhances-the-efficacy-of-doxorubicin-and-vinorelbine-in-breast-cancer-cells
#11
JOURNAL ARTICLE
Zahra Abbasfard, Abbas Behzad-Behbahani, Banafshe Rastegari, Sirous Naeimi, Mehdi Moghanibashi, Fatemeh Safari
BACKGROUND: Breast cancer remains a leading cause of cancer-related deaths among women, primarily attributed to the formidable challenge of multidrug resistance, often driven by the overexpression of the ABCB1 gene. OBJECTIVE: This study aimed to assess the synergistic effects of siRNA, doxorubicin, and vinorelbine on ABCB1 gene expression and cell viability in doxorubicin-resistant MCF-7/ADR breast cancer cells, with siRNA targeting ABCB1 to reduce its expression and doxorubicin/ vinorelbine to eradicate cancer cells...
April 9, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38616722/long-term-safety-of-desmopressin-orally-disintegrating-tablets-in-men-with-nocturia-due-to-nocturnal-polyuria-interim-results-of-a-specified-drug-use-results-survey-in-japan
#12
JOURNAL ARTICLE
Yoshimasa Ogawa, Shujiro Murata, Kiyotoshi Kuramoto, Atsushi Nakano
OBJECTIVES: This interim report presents the 12-week results of a post-marketing surveillance evaluating the safety of desmopressin orally disintegrating tablets 25 and 50 μg in Japanese men with nocturia due to nocturnal polyuria. METHODS: Of the planned study population of 1000 Japanese men receiving desmopressin for the first time for nocturia due to nocturnal polyuria, 971 cases were enrolled. In this interim analysis, 9 cases, including 6 registry violations and 3 cases of unconfirmed desmopressin dosing, were excluded from the 354 case report forms collected and fixed by the end of December 2021, and data up to 12 weeks after administration in 345 cases were defined as the safety analysis set...
May 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/38615313/the-temporal-association-between-adverse-drug-reactions-and-antirheumatic-drugs-utilisation-in-western-australia-a-retrospective-study-from-real-world-data-1995-2015
#13
JOURNAL ARTICLE
Khalid B Almutairi, Charles A Inderjeeth, David B Preen, Helen I Keen, Johannes C Nossent
BACKGROUND/OBJECTIVES: Adverse drug reactions (ADRs) can result in morbidity, mortality, and higher healthcare costs. Given the limited information available on ADRs associated with antirheumatic medications, this study aims to analyse and compare ADR reporting for these drugs in the pharmacovigilance datasets of Western Australia (WA) and the United States (US). METHODS: Therapeutic Goods Administration provided WA pharmacovigilance data of selected antirheumatic drugs to from 1995 to 2015...
April 14, 2024: Rheumatology International
https://read.qxmd.com/read/38614218/uv-aged-polystyrene-nanoplastics-aggravate-intestinal-barrier-damage-by-overproduction-of-ros
#14
JOURNAL ARTICLE
Tianjiang Jia, Jin Cai, Shiyu He, Zhen Mao, Xiaodan Zhang, Aobo Geng, Hong Yang, Shuqin Jiang, Peili Huang
UV irradiation significantly alters nanoplastics (NPs) physicochemical properties, thus affecting their biological toxicity. This study is the first to assess the influence of virgin and UV-aged polystyrene NPs (v-PS NPs, a-PS NPs) on the intestinal barrier of ICR mice. We found that a-PS NPs can cause more severe intestinal barrier damage compared with v-PS NPs. The reason may be attributed to that a-PS NPs produced more ROS in intestinal tissue. Moreover, the strong oxidizing property of hydroxyl radicals (·OH) generated from the a-PS NPs can damage cell membranes through lipid peroxidation, thereby leading to a low clearance rate of ·OH due to the impaired intestinal tissue function, in turn, causing more ROS to accumulate and inducing severe oxidative damage...
April 11, 2024: Environmental Toxicology and Pharmacology
https://read.qxmd.com/read/38613920/s-nitrosocysteamine-functionalised-porous-graphene-oxide-nanosheets-as-nitric-oxide-delivery-vehicles-for-cardiovascular-applications
#15
JOURNAL ARTICLE
Tanveer A Tabish, Mian Zahid Hussain, Sevasti Zervou, William K Myers, Weiming Tu, Jiabao Xu, Irina Beer, Wei E Huang, Rona Chandrawati, Mark J Crabtree, Paul G Winyard, Craig A Lygate
Nitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However, many NO donors are associated with the development of tolerance and adverse effects, so new formulations for controlled and targeted release of NO would be advantageous. Herein, we describe the design and characterisation of a novel NO delivery system via the reaction of acidified sodium nitrite with thiol groups that had been introduced by cysteamine conjugation to porous graphene oxide nanosheets, thereby generating S-nitrosated nanosheets...
April 4, 2024: Redox Biology
https://read.qxmd.com/read/38613741/efficacy-and-safety-of-telitacicept-in-patients-with-lupus-nephritis-a-single-center-real-world-retrospective-study
#16
JOURNAL ARTICLE
Xiaolu Huang, Fuan Lin, Hongpu Chen
BACKGROUND: Telitacicept, an innovative drug used for the treatment of systemic lupus erythematosus (SLE), can effectively control disease progression and achieve favorable outcomes. While case reports have mentioned the use of Telitacicept in lupus nephritis (LN) treatment, its safety and efficacy in treating patients with LN have not been explored. Therefore, in this study, we aimed to evaluate the safety and efficacy of Telitacicept in managing patients with LN. METHODS: In a single-center, real-world retrospective study, 30 LN patients with poor response or adverse reactions to conventional glucocorticoids at our Hospital were enrolled to receive Telitacicept...
April 13, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38613561/association-of-hla-a%C3%A2-11-01-hla-b%C3%A2-39-01-and-hla-b%C3%A2-56-03-with-salazosulfapyridine-induced-cutaneous-adverse-drug-reactions
#17
JOURNAL ARTICLE
Koya Fukunaga, Eri Tsukagoshi, Ryosuke Nakamura, Kayoko Matsunaga, Takeshi Ozeki, Hideaki Watanabe, Akito Hasegawa, Natsumi Hama, Maiko Kurata, Yoshiko Mizukawa, Yuko Watanabe, Yukie Yamaguchi, Hiroyuki Niihara, Eishin Morita, Hideo Asada, Riichiro Abe, Yoshiro Saito, Taisei Mushiroda
No abstract text is available yet for this article.
April 1, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38613254/optimizing-co-prescription-of-clozapine-and-antiseizure-medications-a-systematic-review-and-expert-recommendations-for-clinical-practice
#18
REVIEW
Hélène Verdoux, Clélia Quiles, Jose de Leon
INTRODUCTION: Antiseizure medication (ASM) add-on to clozapine may be efficient to target clozapine-resistant mood or psychotic symptoms or clozapine-related adverse drug reactions (ADR) such as seizures. We aimed to synthesize the information relevant for clinical practice on the risks and benefits of clozapine-ASM co-prescription. AREAS COVERED: Articles were identified with MEDLINE, Web of Sciences and PsycINFO search from inception through October 2023. The review was restricted to ASM with mood-stabilizing properties or with potential efficacy for resistant psychotic symptoms (valproate (VPA), lamotrigine, topiramate, carbamazepine, oxcarbazepine)...
April 13, 2024: Expert Opinion on Drug Metabolism & Toxicology
https://read.qxmd.com/read/38612660/advancements-in-regenerative-hydrogels-in-skin-wound-treatment-a-comprehensive-review
#19
REVIEW
Gabriel Olteanu, Sorinel Marius Neacșu, Florin Alexandru Joița, Adina Magdalena Musuc, Elena Carmen Lupu, Corina-Bianca Ioniță-Mîndrican, Dumitru Lupuliasa, Magdalena Mititelu
This state-of-the-art review explores the emerging field of regenerative hydrogels and their profound impact on the treatment of skin wounds. Regenerative hydrogels, composed mainly of water-absorbing polymers, have garnered attention in wound healing, particularly for skin wounds. Their unique properties make them well suited for tissue regeneration. Notable benefits include excellent water retention, creating a crucially moist wound environment for optimal healing, and facilitating cell migration, and proliferation...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610210/potential-applications-of-artificial-intelligence-ai-in-managing-polypharmacy-in-saudi-arabia-a-narrative-review
#20
REVIEW
Safaa M Alsanosi, Sandosh Padmanabhan
Prescribing medications is a fundamental practice in the management of illnesses that necessitates in-depth knowledge of clinical pharmacology. Polypharmacy, or the concurrent use of multiple medications by individuals with complex health conditions, poses significant challenges, including an increased risk of drug interactions and adverse reactions. The Saudi Vision 2030 prioritises enhancing healthcare quality and safety, including addressing polypharmacy. Artificial intelligence (AI) offers promising tools to optimise medication plans, predict adverse drug reactions and ensure drug safety...
April 5, 2024: Healthcare (Basel, Switzerland)
keyword
keyword
38227
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.